scorecardresearch
Thursday, November 7, 2024
TopicCovid-19 vaccine

Topic: Covid-19 vaccine

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

Bankers want to be ‘frontline workers’ who get Covid vaccine first, write to Sitharaman

Four bank unions say bankers have provided yeoman service throughout Covid pandemic, and will feel appreciated if they’re moved up in priority list.

Indian travel agencies plan ‘vaccine tourism’ with packages for UK, US and Russia

A few travel agencies are already formulating tour packages for Indians who want to travel to the UK and avail the recently-approved Pfizer-BioNTech Covid vaccine.

Now, Russian scientists find link between BCG vaccine & Covid-19 immunity

Study by St. Petersburg University researchers suggests BCG vaccine may protect against severe Covid, adds to research linking TB vaccine to coronavirus.

Wait for Covid vaccine won’t be long, experts say a few weeks — PM Modi at all-party meet

PM Modi tells leaders that 8 probable vaccines in different stages of trial can be manufactured in India, Centre & states working on distribution plan.

Vaccines not the only solution to Covid, past viral infections are key too

Three doctors who sat at lunch with a Covid-infected colleague in a Delhi hospital didn’t get infected. Once we know why, we’ll also know who to vaccinate.

Sputnik V Covid vaccine likely to be available for supply by next month, says Russia’s RDIF

Calling Sputnik V a joint effort between Russia and India, RDIF CEO Kirill Dmitriev tells ThePrint that Russia is keen to collaborate with other countries on development of Covid vaccines.

Anand Sharma goes against Congress’ official line, welcomes PM Modi’s Covid vaccine review tour

Rajya Sabha MP and senior Congress leader Anand Sharma said Modi’s visits to three vaccine makers Saturday would lift morale and reassure the nation.

Alleging serious side-effects, vaccine trial participant seeks Rs 5 cr from Serum Institute

Chennai-based participant also sends legal notice to ICMR, DCGI, AstraZeneca & Oxford University to stop testing, manufacturing & distributing vaccine.

With Covid vaccine coming, Modi govt tells states & UTs to boost ways to report side effects

India began ‘Adverse Events Following Immunisation’ surveillance on mother and child immunisation in 1988, but Covid has thrown up new challenges.

On Camera

Trump has called Delhi a big abuser of tariffs. India-US economic ties are about to change

How Trump responds to the growing Russia-China alliance and their anti-American diatribes will require some strategising among the Indian foreign policy and national security mandarins.

How Adani halving power supply to Bangladesh could land the country in ‘dire straits’

Bangladesh is already reeling from low coal-fired power production & inability to import enough coal, gas. Now, Adani has cut supplies over unpaid dues. However, this could hurt Adani too.

India, Bangladesh Army chiefs discuss issues of ‘mutual interest’

Video call between two Army heads is their first interaction after political upheaval in Bangladesh forced former prime minister Sheikh Hasina to flee to India in August.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.